About Lou Jayco (Jay) Rabanzo
Jay leads the analytical rigor that underpins Douglas CDMO’s manufacturing excellence. With deep expertise in laboratory operations, he oversees the analytical method validation of high‑potency formulations and complex drug delivery systems, ensuring that sophisticated analytical data is translated into robust, compliant manufacturing outcomes. Jay plays a pivotal role in the technical transfer of analytical methods, ensuring that each project aligns seamlessly with global regulatory expectations, including those of the FDA, TGA, PIC/S, EMA and Medsafe.
Across a career spanning more than 20 years, Jay has built a diverse international portfolio across the Philippines, Saudi Arabia, the United States, European Region, APAC and New Zealand. Before joining Douglas, he held senior regulatory and compliance leadership roles, including Chief of Testing and Quality Assurance Laboratory at the Philippines Food and Drug Administration (FDA) and Compliance Lead at Arbour Group (PharmaLex-US). During his time in Saudi Arabia, he led analytical method transfers involving Eli Lilly, AstraZeneca, MSD, GSK and other top tier global pharmaceutical manufacturers. His background combines hands-on scientific leadership with regulatory strategy, enabling him to guide complex pharmaceutical programs with precision and foresight.
Jay holds a degree in Postgraduate Certificate in Applied Science (Biomedical Science and Technology), graduated with Distinction from the Auckland University of Technology and Postgraduate Diploma in Applied Management from Eastern Institute of Technology, New Zealand. He is a certified ISO 9001:2015 Lead Auditor and an internal auditor for ISO 17025. His blend of scientific expertise, regulatory insight, and global experience positions him as a key contributor to advancing quality excellence in pharmaceutical development, transfer and manufacturing.
Across a career spanning more than 20 years, Jay has built a diverse international portfolio across the Philippines, Saudi Arabia, the United States, European Region, APAC and New Zealand. Before joining Douglas, he held senior regulatory and compliance leadership roles, including Chief of Testing and Quality Assurance Laboratory at the Philippines Food and Drug Administration (FDA) and Compliance Lead at Arbour Group (PharmaLex-US). During his time in Saudi Arabia, he led analytical method transfers involving Eli Lilly, AstraZeneca, MSD, GSK and other top tier global pharmaceutical manufacturers. His background combines hands-on scientific leadership with regulatory strategy, enabling him to guide complex pharmaceutical programs with precision and foresight.
Jay holds a degree in Postgraduate Certificate in Applied Science (Biomedical Science and Technology), graduated with Distinction from the Auckland University of Technology and Postgraduate Diploma in Applied Management from Eastern Institute of Technology, New Zealand. He is a certified ISO 9001:2015 Lead Auditor and an internal auditor for ISO 17025. His blend of scientific expertise, regulatory insight, and global experience positions him as a key contributor to advancing quality excellence in pharmaceutical development, transfer and manufacturing.
Areas of expertise
Insights by Lou Jayco (Jay) Rabanzo
Work with Lou Jayco (Jay) Rabanzo’s team
Talk to Douglas CDMO about formulation, development and manufacturing for your molecule.
Get In Touch